Jeanne Lenzer - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Jeanne Lenzer's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Jeanne Lenzer

Jeanne Lenzer

Verified

Investigative Journalist, The BMJ

New York

Biography

I am an independent medical investigative journalist and former Knight Science Journalism fellow. My book, The Danger Within Us: America's Untested, Unregulated Medical Device Industry and One Man's Battle to Survive It, will be published by Little, Brown December 12, 2017. I have been a regular contributor to the international medical journal, The BMJ, and my articles, reviews, and commentary have appeared in The New York Times Magazine, The Atlantic, The New Republic, Discover, Slate, Washington Monthly, The Scientist, The (London) Independent, USA Today, Newsweek Japan, Mother Jones, and many other outlets. I am interested in legal corruption, not individual wrong-doing but the sort of structural, cultural practices that undermine the public well-being.

Final Covers

endocrinology, COVID-19, women's health pulmonology, alcohol/drug abuse, FDA. headache/migraine, immunization, chronic pain obesity, cardiology, dermatology sexual health, influenza,Mental health

Doesn’t Cover

Family scandals, i respect peoples privacy

Journalist Type

-

Seniority Positions

-

Medium Formats

-

Content

Total articles 99

  • Big Pharma Is Pushing Potentially Deadly Alzheimer’s Drugs

    By Jeanne Lenzer| Jacobin Verified Six years ago, Genevieve Lane was enjoying an active life in Florida when she began to forget her neighbors’ names and where she put her keys. At seventy-six, she might have shrugged off these lapses as mere signs of aging, but when she began to have moments of confusion and occasionally got lost while out walking, her housemate and longtime friend Vicki Holmes told her about a nearby research center.

    By Jeanne Lenzer · Jacobin

    Feb. 01, 2025

  • The Deadly Secrets Behind “Breakthrough” Alzheimer’s Drugs

    By Jeanne Lenzer| The Lever Verified This article is part of an investigation into the Food and Drug Administration’s drug approval process and what it means for the public’s safety and health. The project is supported by The Lever and the McGraw Center for Business Journalism at CUNY Newmark School of Journalism. Six years ago, Genevieve Lane was enjoying an active life in Florida when she began to forget her neighbors’ names and where she put her keys.

    By Jeanne Lenzer · The Lever

    Jan. 28, 2025

  • New Alzheimer’s Drugs Shrink Your Brain - Is That Bad?

    By Jeanne Lenzer| The Lever Verified This full story is for paid subscribers. Sign up for a paid subscription to The Lever now to gain access to this story and more. Already have an account? Sign in

    By Jeanne Lenzer · The Lever

    Jan. 28, 2025

As seen in

Company Info

The BMJ

BMJ, or British Medical Journal, is a prominent global healthcare knowledge provider established in 1840. The organization focuses on improving health worldwide by enhancing the creation and sharing of medical research, advancing clinical education, and advocating for high-quality healthcare. BMJ offers a variety of services and products for healthcare professionals, researchers, educators, and the public. This includes the BMJ Journal, which publishes original research and commentary on clinical practice and healthcare policy. They also provide educational resources and courses, digital platforms for disseminating healthcare information, and organize live events and conferences for networking and discussion among healthcare professionals. The company is led by CEO Chris Jones and is headquartered in London. BMJ serves a diverse audience, including healthcare professionals, researchers, educators, policymakers, and the general public, all of whom benefit from its extensive resources and advocacy efforts.

London, United Kingdom

+44 20 7387 4410

Founded: 1840